Delivery Order SPE2DB24D2205-SPE2DB25FEAXA

Award Date 4/11/25
Potential Completion Date 5/2/25
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,891.25 Firm Fixed Price Delivery Order contract is for the supply of AFINITOR 2.5 MG TABLET UD 28S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,333.53, is for the delivery of Afinitor Disperz 5 mg Tablets and has an ultimate completion date of April 24, 2025. This appears to be a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,524.38, is a Delivery Order for the supply of the drug Afinitor 10 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $24,721.64 firm fixed-price delivery order is for the supply of AFINITOR 10 MG TABLET UD 28S, a pharmaceutical product, with a completion date of March 5, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $20,805.32 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of Afinitor 10 mg tablets, a pharmaceutical product used in the treatment of certain medical conditions. The award has an ultimate completion date of September 13, 2024 and does not include a set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with...
This federal contract award, valued at $10,447.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a firm fixed price delivery order. The contract is for the supply of Afinitor 7.5 mg tablets, a specialty pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and has been awarded an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 by DLA to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Afinitor Disperz 5 mg tablets, a specialty medication. The contract has a ceiling value of $12,333.53 and a completion date of February 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $24,721.64, is for the delivery of the pharmaceutical product AFINITOR 10 MG TABLET UD 28S. The contract is not designated as a set-aside and has a completion date of July 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $10,402.66, is for the delivery of AFINITOR 10 MG TABLET UD 28S, a specialty pharmaceutical product. The contract is a firm fixed price arrangement with a completion date of March 28, 2024. No set-aside designation was used...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $35,747.88, to provide AFINITOR DISPERZ 3 MG TABLET 28S. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEAXA
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,600.94, is a Firm Fixed Price Delivery Order for the supply of the drug Afinitor 2.5 mg tablet, with a completion date of May 2, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition.

Generated 7/11/25, 10:12 AM